Cancer, Preventing Prostate Cancer
Feb-22-2007
Prostate cancer is one of the most common forms of cancer in men In fact only skin cancer is more common Over 200 000 men will be diagnosed with prostate cancer this year and one in six men will be diagnosed with the disease during their lifetime But there is some good news about prostate cancer too Of the one in six men who will be diagnosed with prostate cancer only one in 34 will die from the disease And death rates from prostate cancer are declining because of earlier detection and better treatments Prostate cancer is usually a slow growing form of cancer making it an excellent target for prevention Who Gets Prostate Cancer While doctors don amp rsquo t fully understand exactly what causes prostate cancer there are some risk factors that do increase a man amp rsquo s likelihood of developing this disease
New Treatments Prostate Cancer, Prostate Cancer Survival Rates
Feb-18-2007
There are approximately 25 000 men newly diagnosed with prostate cancer every year in the United Kingdom For these men the risk of dying from their prostate cancer depends on a number of risk factors For example if the cancer is confined to the prostate gland at diagnosis the chance of surviving to 5 years is 70 If the cancer has already spread e g to the bones then only 20 of men will survive to five years Of all the men who currently have prostate cancer in the UK approximately 10 000 will die of the disease each year The prostate cancer survival rate is much higher in the developed world unsurprisingly When a man is first diagnosed with prostate cancer then the doctor who has found the cancer most often a amp 8220 urologist amp 8221 amp 8212 a surgeon who specialises in looking after problems to do with the kidneys prostate and bladder will arrange a series of tests to help assess the risk for that individual patient The results of these tests will in turn help the doctor and patient to decide the best treatment for that patient
Research From University Of California Sheds Light On Prostate Cancer
Feb-18-2007
Research conducted from University of California, U.S., has updated our knowledge about prostate cancer. Study 1: Fresh data on prostate cancer are presented in the report "Religious coping and problem-solving by couples faced with prostate cancer." According to a study from the United States, "Religion can be an important resource for people struggling with chronic illness. Problem-solving skills have also been shown to be helpful." "This study examined whether turning to religion as a coping resource would be associated with better problem-solving in couples trying to manage challenges associated with prostate cancer. The sample was 101 patients with prostate cancer and their wives. Wives completed the Social Problem-Solving Invento...
New Study Shows Cough Medicine Effective Against Prostate Cancer
Feb-18-2007
DOVER, Del. -- A presentation made at the 17th International Prostate Cancer Update Conference in Vail, Colorado, has shown noscapine to be effective against prostate cancer. Noscapine, a non-addictive derivative of opium, has been used worldwide since the 1950's as an anti-cough medication. Noscapine was originally proposed as an anti-cancer agent in the early 1960's. However major studies of its broad anti-cancer effects were only done in recent years. The study in prostate cancer is the result of ongoing collaboration between the Prostate Cancer Research and Educational Foundation (PC-REF) and MedInsight Research Institute. Dr. Israel Barken, Founder and Medical Director of the Prostate Cancer Research and Educat...
Study Results From University Of Miami In The Area Of Prostate Cancer Discussed
Feb-18-2007
New prostate cancer study findings have been reported from University of Miami, U.S. Study 1: Fresh data on prostate cancer are presented in the report "Psychosocial and sociodemographic correlates of benefit-finding in men treated for localized prostate cancer." According to recent research published in the journal Psycho-Oncology, "Prostate cancer (PCa) treatment involves decrements in quality of life such as decreased sexual functioning and urinary/bowel incontinence." "Prior work in other cancers has identified positive consequences (e.g. personal growth) following diagnosis and treatment, a phenomenon that has been referred to as benefit-finding (BF) and positively related to quality of life. The present study evaluated demograph...
New Treatments For Prostate Cancer
Feb-20-2007
... effects. One way is to reduce the amount of radiation received by normal organs (bladder, bowel etc) and this has been improving over the last few years with better machines and techniques such as ?conformal radiotherapy? and ?IMRT?.
Work is also being carried out on combining brachytherapy with external therapy to allow some of the benefits of brachytherapy (fewer side effects, higher overall dose to the prostate cancer) to be used for men with more advanced prostate cancer without compromising the chance of cure.
NEW HORMONE THERAPY FOR PROSTATE CANCER
Some newer prostate cancer hormone treatments have fewer side effects than older hormone based drugs. Some are also felt to be more effective. All the time researchers are testing to try and find the best hormone tablets or injections...
The Key Facts Behind Prostate Cancer
Feb-20-2007
Prostate cancer is the most commonly diagnosed cancer of UK men. If it is found early and is still confined to the gland itself then the chances of survival are excellent. Modern surgical techniques, combined with drugs such as Viagra, mean that an operation to treat prostate cancer does not signal the end of a patient's sex-life. The prostate itself is a small, walnut-sized gland situated near the bladder in men that produces one component of semen. There are a broad range of prostate cancers, ...
Variation In The Definition Of Biochemical Recurrence In Patients Treated For Localized Prostate Cancer
Feb-19-2007
UroToday.com- One of the problems with prostate cancer outcomes studies is the lack of standardization in the definition of "treatment failure". While after radical prostatectomy most experts would agree that a serum PSA concentration greater than 0.2 ng/ml constitutes a recurrence, some institutions use 0.1 ng/ml and others use 0.4 ng/ml. [click link for full article]
Body Mass Index, Weight Change, And Risk Of Prostate Cancer In The Cancer Prevention Study II Nutrition Cohort
Feb-19-2007
UroToday.com- In the last five years, a large body of evidence has been accumulated supporting the association between obesity and high-risk prostate cancer. Despite this advancement in our knowledge of prostate carcinogenesis, the exact interplay between BMI and patient risk remains poorly understood. [click link for full article]
New drugs show promise for prostate cancer
Feb-19-2007
U.S. oncologists say a new class of targeted anti-cancer drugs shows promise in prolonging the lives of patients with recurrent prostate cancer.
New Drugs Show Promise For Prostate Cancer
Feb-20-2007
U.S. oncologists say a new class of targeted anti-cancer drugs shows promise in prolonging the lives of patients with recurrent prostate cancer....
Tests May Spot Most Deadly Prostate Cancers
Feb-22-2007
Title: Tests May Spot Most Deadly Prostate Cancers
Category: Health News
Created: 2/23/2007 2:00:00 AM
Last Editorial Review: 2/23/2007
Category: Health News
Created: 2/23/2007 2:00:00 AM
Last Editorial Review: 2/23/2007
Prostate Cancer Overtreated?
Feb-22-2007
Title: Prostate Cancer Overtreated?
Category: Health News
Created: 2/23/2007
Last Editorial Review: 2/23/2007
Category: Health News
Created: 2/23/2007
Last Editorial Review: 2/23/2007
Parenteral oestrogens for prostate cancer
Feb-20-2007
The purpose of this review was to examine the literature on the use of parenteral oestrogens (e.g.
administered intravenously, intramuscularly, subcutaneously or transdermally) in prostate cancer, in
order to inform the design of a randomised clinical trial. [CRD Report 33]
Bill pitches free prostate cancer tests
Feb-21-2007
The proposal would require all health insurers in the state to pay for physical exams and blood tests to detect prostate cancer.
Prostate Cancer Therapy May Increase Risk Of Death From Heart Disease In Older Men
Feb-24-2007
Science Daily - Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease in patients over age 65, according to a new study by ...
Protox Announces PRX302 Data to Be Presented at ASCO Sponsored Prostate Cancer Symposium
Feb-23-2007
Protox Therapeutics Inc. today announced that additional pre-clinical efficacy and safety data on PRX302, a novel pore-forming targeted toxin, will be presented this week at the Prostate Cancer Symposium, a ...
Tests May Spot Most Deadly Prostate Cancers
Feb-22-2007
Physicians may soon be able to identify which men have a more deadly form of prostate cancer, U.S. researchers report.
Men With Prostate Cancer More Optimistic After Several Years Of Treatment Than At Diagnosis, Reveals Global Survey
Feb-19-2007
Men being treated for prostate cancer feel more optimistic about their condition over time, reflecting their positive experience of treatment and the high level of trust they have in their specialist physician, according to results from a global survey1 providing unique insight into men's experience of this common cancer. [click link for full article]
Tests May Spot Most Deadly Prostate Cancers
(HealthDay)
Feb-22-2007
HealthDay - THURSDAY, Feb. 22 (HealthDay News) -- Physicians may soon be able
to identify which men have a more deadly form of prostate cancer, U.S.
researchers report.
Prostate cancer screenings offered
Feb-22-2007
Gulf Coast Cancer Centers will hold a prostate cancer screening for the public at the Monroeville office, Southwest Alabama Community Cancer Center, on Thursday, March 1 from 11 a.m. to 1 p.m. Gulf Coast Cancer ...
Qualitative Analysis of Couples' Experience With Prostate Cancer by Age Cohort
Feb-20-2007
Findings indicated that similarities and differences exist when couples of different ages deal with prostate cancer.
Cancer nursing
Cancer nursing
Exercise helps in prostate cancer
Feb-23-2007
Exercising improves the quality of life for men being treated with radiation for prostate cancer, according to U.S. researchers.
Prostate cancer therapy may increase risk of death from heart disease in older men
Feb-23-2007
Androgen deprivation therapy -- one of the most common treatments for prostate cancer -- may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.
Prostate cancer therapy may increase risk of death from heart disease in older men
Feb-24-2007
Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at ...
Baptist to perform clinical trial of prostate cancer therapy
Feb-21-2007
A collaboration of Baptist Memorial Health Care Corp. and local urologists is the first group in the nation approved for Phase III clinical trials of a prostate cancer therapy that destroys cancer cells with sound waves.
Protox Reports Promising Interim Results from Prostate Cancer Study
Feb-19-2007
(PharmaLive) VANCOUVER, Jan. 18 /CNW/ - Protox(TM) Therapeutics Inc. (TSX-V:PRX) today announced interim results from its ongoing Phase I clinical trial evaluating PRX302 in patients with localized, recurrent prostate cancer. The findings to date indicate that PRX302 is well tolerated and shows encouraging signs of therapeutic activity following a single intra-prostatic injection.
Antisoma encouraged by cancer drug data
Feb-23-2007
UK biotech firm Antisoma has reported positive interim findings from its ongoing phase II trial of AS1404 in hormone-refractory prostate cancer.
Monroe s Mayor Undergoing Cancer Treatments
Feb-20-2007
The Mayor of the City of Monroe, Michigan has cancer. Mayor Al Cappuccilli , 76, is being treated for prostate cancer.
Radiation information available in Spanish
Feb-23-2007
The American Society for Therapeutic Radiology and Oncology is offering Spanish versions of brochures on radiation therapy for breast and prostate cancer.
Medivation to present early data on cancer drug
Feb-19-2007
Medivation Inc. said it will present preclinical efficacy data on a prostate cancer drug it intends to test in clinical trials later this year.
Researcher identifies men who require second prostate biopsy
Feb-22-2007
Mark Garzotto, M.D., has been invited to present his findings on Thursday, Feb. 22, at the Multidisciplinary Prostate Cancer Symposium in Orlando, Fla.
State treasurer diagnosed with cancer
Feb-20-2007
- State Treasurer Vern Larson said Friday he has been diagnosed with prostate cancer and will have surgery next month.